Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2)
7 Berlin Institute of Health, Comprehensive Allergy Center, Department of Dermatology and Allergy, Berlin, Germany.
8 EUFOREA, Brussels, Belgium.
9 Allergy Department, Pasteur Institute, Paris, France.
10 Faculty of Medicine, Transylvania University, Brasov, Romania.
11 Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, INSERM and Sorbonne Universités, Medical School Saint Antoine, Paris, France.
12 Department of Allergy and Immunology, Hospital Quirónsalud Bizkaia, Erandio, Spain.
13 ISGlobAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
15 CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
16 Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
17 National Center of Expertise in Cognitive Stimulation (CEN STIMCO), Broca Hospital, Paris, France.
18 Mines ParisTech CRI - PSL Research University, Fontainebleau, France.
19 iQ4U Consultants Ltd, London, UK.
20 Independent Consultant, Joensuu, Finland.
21 Woolcock Institute of Medical Research, University of Sydney and Woolcock Emphysema Centre and Sydney Local Health District, Glebe, NSW, Australia.
22 Allergist, La Rochelle, France.
23 Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
24 Imperial College London-National Heart and Lung Institute, London, UK.
25 Personalized Medicine Clinic Asthma & Allergy, Humanitas Clinical and Research Center IRCCS, Rozzano (MI), and Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy.
26 Institute for Immunological Research, University of Cartagena, Campus de Zaragocilla, Edificio Biblioteca Primer piso, Cartagena, Colombia, and Foundation for the Development of Medical and Biological Sciences (Fundemeb), Cartagena, Colombia.
27 Allergy Section, Department of Internal Medicine, Hospital Vall d'Hebron & ARADyAL research network, Barcelona, Spain.
28 Regional Ministry of Health of Andalusia, Seville, Spain.
29 College of Psychology, Nova Southeastern University and School-related Psychological Assessments and Clinical Interventions Clinic, Ft Lauderdale, Florida, USA.
30 SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy.
31 Department of Health Research Methods, Evidence, and Impact, Division of Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
32 Department of Health, Social Services and Public Safety, Northern Ireland, Belfast, UK.
33 UCIBIO, REQUIMTE, Faculty of Pharmacy, and Competence Center on Active and Healthy Ageing of University of Porto (AgeUPNetWork), University of Porto, Porto, Portugal.
34 ProAR-Nucleo de Excelencia em Asma, Federal University of Bahia, Brasil and WHO GARD Executive Committee, Bahia, Brazil.
35 Medical Consulting Czarlewski, Levallois, France.
36 Allergy and Clinical Immunology Section, National Heart and Lung Institute, Imperial College London, London, UK.
37 Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Japan.
38 National Institute for Health and Welfare, Helsinki, Finland.
39 CHU Clermont-Ferrand, Unité d'Allergologie de l'Enfant, Pôle Pédiatrique, Hôpital Estaing, Clermont-Ferrand, France.
40 Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, the Netherlands.
41 CINTESIS, Center for Research in Health Technology and Information Systems, Faculdade de Medicina da Universidade do Porto; and Medida, Lda Porto, Portugal.
42 Institute of Health Policy and Management iBMG, Erasmus University, Rotterdam, the Netherlands.
43 Department of Otorhinolaryngology, Chiba University Hospital, Chiba, Japan.
44 Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
45 Center for Rhinology and Allergology, Wiesbaden, Germany.
46 Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
47 Institute of Biomedical Sciences, Department of Pathology, Faculty of Medicine, Vilnius University, and Institute of Clinical Medicine, Clinic of Chest diseases and Allergology, Faculty of Medicine, Vilnius, Lithuania.
48 Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico.
49 KYomed INNOV, Montpellier, France.
50 University of Medicine and Pharmacy, Hochiminh City, Vietnam.
51 Faculty of Health Sciences and CICS-UBI, Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.
52 Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, and Ageing@Coimbra EIP-AHA Reference Site, Coimbra, Portugal.
53 CIRFF, Center of Pharmacoeconomics, University of Naples Federico II, Naples, Italy.
54 Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic; Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
55 Danish Committee for Health Education, Copenhagen East, Denmark.
56 Division of Infection, Immunity & Respiratory Medicine, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK.
57 Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou", University of Athens, Athens, Greece.
58 University of Oulu, Faculty of Medicine, Oulun Yliopisto, Finland.
59 Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Phillipps-Universität Marburg, Germany.
60 Department of Health and Social Services, Welsh Government, Cardiff, UK.
61 Director, Centre For Empowering Patients and Communities, Dublin, Ireland.
62 Asthma UK Centre for Applied Research, The Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
63 Agency for Social Services and Dependency, Regional Government for Equality, Social Policies and Conciliation of Andalucia, Seville, Spain.
64 Association Asthme et Allergie, Paris, France.
65 KanopyMed, Paris, France.
66 Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
67 Allergy and Clinical Immunology Department, Centro Medico-Docente La Trinidad, Caracas, Venezuela.
68 Immunomodulation and Tolerance Group, Imperial College London, and Allergy and Clinical Immunology, Imperial College London, London, UK.
69 European Health Futures Forum (EHFF), Dromahair, Ireland.
70 Division of Allergy, Immunology, and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA.
71 Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
72 Health Planning Unit, Department of Social Medicine, Faculty of Medicine, University of Crete, Crete, Greece and International Primary Care Respiratory Group IPCRG, Aberdeen, Scotland.
73 National Heart and Lung Institute (NHLI), Imperial College London & Royal Brompton Hospital, Airways Disease Section, London, UK.
74 Asthma UK, London, UK.
75 Nova Southeastern University, Fort Lauderdale, Florida, USA.
76 Vilnius University Faculty of Medicine, Institute of Clinical Medicine & Institute of Health Sciences, Vilnius, Lithuania.
77 Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, the Netherlands.
78 University of Bari Medical School, Unit of Geriatric Immunoallergology, Bari, Italy.
79 International Primary Care Respiratory Group IPCRG, Aberdeen, Scotland.
80 Department of Pulmonary Diseases, Celal Bayar University, Faculty of Medicine, Manisa, Turkey.
81 Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Uniersität zu Berlin and Berlin Institute of Health, Comprehensive Allergy-Centre, Department of Dermatology and Allergy, Member of GA2LEN, Berlin, Germany.